Introducing Factor XI: Isis Says New Anticoagulant Has Less Bleeding And Antidote
This article was originally published in The Pink Sheet Daily
Executive Summary
Candidate has potential across the board, but most likely will first be developed in two targeted indications where available anticoagulants are not typically an option due to bleeding risk.